• Safety & Recalls
  • Regulatory Updates
  • Drug Coverage
  • COPD
  • Cardiovascular
  • Obstetrics-Gynecology & Women's Health
  • Ophthalmology
  • Clinical Pharmacology
  • Pediatrics
  • Urology
  • Pharmacy
  • Idiopathic Pulmonary Fibrosis
  • Diabetes and Endocrinology
  • Allergy, Immunology, and ENT
  • Musculoskeletal/Rheumatology
  • Respiratory
  • Psychiatry and Behavioral Health
  • Dermatology
  • Oncology

Pipeline Preview (May 2006)

Article

Approvable designations

Approvable designations

• Sitaxsentan (Thelin, Encysive Pharmaceuticals) for the treatment of pulmonary arterial hypertension

Fast-track designations

Priority review

• Infliximab (Remicade, Centocor) for pediatric Crohn's disease

Orphan drug designations

• Cell-permeable peptide (AM-111, Auris Medical) for acute sensorineural hearing loss

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.